Navigation Links
New Drug More Effective than Tamoxifen in Preventing Breast Cancer Relapse

New research appearing in the December 29 issue of the New England Journal of Medicine says that a new drug called as Femara is better than tamoxifen fro preventing the chances // of a relapse of breast cancer. Femara is a drug manufactured by Novartis AG and is chemically letrozole.

This belongs to a class of drugs called as the aromatase inhibitors of which Arimidex is also a part. In the current study, which was co-ordinated by the Senology Center of Eastern Switzerland in Kantonsspital, 8,000 women were assessed after taking either tamoxifen or Femara. It was found that Femara reduced the chances of breast cancer relapse by 29 percent over what tamoxifen achieved. In addition to this, Femara also conferred a 27 percent less chance of metastasis of the cancer to other parts of the body. Tamoxifen is regarded as the "gold standard" in treatment of breast cancer, but this new class of drugs is demonstrating better results in hormone-sensitive breast cancer. This is especially true in post-menopausal women, who are more prone to develop estrogen-related breast cancer. Femara works by reducing the levels of this hormone, which is essential to trigger the growth of tumors, whereas tamoxifen prevents the entry of estrogen into cancer cells. . "Five years of treatment with tamoxifen reduces the risk of breast cancer recurrence by 47% and the risk of death by 26%," wrote Dr. Beat Thurlimann and colleagues. "Despite these benefits, about half the women so treated relapse."

Femara has now been approved by the U.S. Food and Drug Administration fro use in post-menopausal women who have undergone surgery for hormone-sensitive early-stage breast cancer.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... , ... Goodcents Deli Fresh Subs today announced the opening of a new ... St. Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by ... locations in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and ... has selected 21 leaders from government, business and civil society in 11 countries across ... U.S. this fall, engaging in a transformative exchange of knowledge and ideas with the ...
(Date:6/23/2017)... ... , ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an ... 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for ... Denmark in 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in ...
(Date:6/23/2017)... TX (PRWEB) , ... June 23, 2017 , ... All-Star ... to residential and business clients throughout eastern Texas, is announcing the launch of a ... , Recent breast cancer statistics in the United States reveal that an estimated 252, ...
(Date:6/22/2017)... ... 22, 2017 , ... Plastic Surgery Associates is proud to report that founding ... year, research and information firm, Castle Connolly, releases their list of the most notable ... the 3rd time that Dr. Canales has been recognized by Castle Connolly. ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ... that they will host a live, complimentary webinar titled, ... the benchtop to the real world" on Wednesday June ... This webinar will feature interviews with ... look into the manipulation techniques abusers use to prepare ...
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: